Spencer Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2010	FY 2009	FY 2008
Period Ending	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Cash & Equivalents	0.46	-	-
Cash & Short-Term Investments	0.46	-	-
Total Current Assets	0.46	-	-
Other Intangible Assets	0.32	0.06	-
Total Assets	0.77	0.06	-
Accounts Payable	0.47	-	-
Short-Term Debt	1.17	0.06	-
Total Current Liabilities	1.64	0.06	-
Total Liabilities	1.64	0.06	-
Common Stock	0.27	0.2	0.01
Additional Paid-In Capital	16.95	16.95	14.59
Retained Earnings	-18	-17.05	-17.05
Comprehensive Income & Other	-0.09	-0.1	2.46
Shareholders' Equity	-0.87	-	-
Total Liabilities & Equity	0.77	0.06	-
Total Debt	1.17	0.06	-
Net Cash (Debt)	-0.72	-0.06	-
Net Cash Per Share	-0.00	-0.00	-
Filing Date Shares Outstanding	271.27	202.93	48.28
Total Common Shares Outstanding	271.27	202.93	48.28
Working Capital	-1.19	-0.06	-
Book Value Per Share	-0.00	-	-
Tangible Book Value	-1.19	-0.06	-
Tangible Book Value Per Share	-0.00	-0.00	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.